Introduction {#Sec1}
============

Enterococci commonly reside in the gastro-intestinal tract of a wide variety of invertebrate and vertebrate hosts, including humans. Since they produce bacteriocins, [*Enterococcus*](http://doi.org/10.1601/nm.5525) spp. are widely used as starter cultures for food fermentations or probiotic supplements \[[@CR1]\]. Since the 1970s however, they have enigmatically progressed from commensal organisms of little clinical interest to leading nosocomial pathogens causing infections of the urinary tract, bloodstream, and surgical wounds, among others \[[@CR2]\]. The large majority of human enterococcal infections are caused by two species: [*E. faecalis*](http://doi.org/10.1601/nm.5526) and [*E. faecium*](http://doi.org/10.1601/nm.5535). Worryingly, acquired antibiotic resistance against a multitude of drugs is increasingly being reported in these organisms \[[@CR3]\].

Here, we report the draft genome of [*E. faecium*](http://doi.org/10.1601/nm.5535)[LMG 8148](http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DLMG+8148), a strain of human origin isolated in 1968 in [Gothenburg, Sweden](https://www.google.com/maps/place/Gothenburg,+Vastra+Gotaland,+Sweden) \[[@CR4]\].

Organism information {#Sec2}
====================

Classification and features {#Sec3}
---------------------------

[*Enterococcus*](http://doi.org/10.1601/nm.5525) is a large genus of Gram-positive, non-sporulating, facultative anaerobic, round-shaped, lactic acid-producing bacteria (Table [1](#Tab1){ref-type="table"}) \[[@CR5]\]. [*E. faecium*](http://doi.org/10.1601/nm.5535) belongs to the family [*Enterococcaceae*](http://doi.org/10.1601/nm.5524), order [*Lactobacillales*](http://doi.org/10.1601/nm.5318), class [*Bacilli*](http://doi.org/10.1601/nm.4854), and phylum [*Firmicutes*](http://doi.org/10.1601/nm.3874). Microscopically, enterococci are often observed as pairs or short chains of cells (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR5]\]. They were classified as group D streptococci until assigned a separate genus in 1984 \[[@CR6]\]. [*E. faecalis*](http://doi.org/10.1601/nm.5526) and [*E. faecium*](http://doi.org/10.1601/nm.5535) are the two most prominent species within the genus. Enterococci can grow in a wide range of environmental conditions, including temperature (5-50 °C), pH (4.6-9.9), 40 % (w/v) bile salts, and 6.5 % NaCl \[[@CR7]\]. To investigate evolutionary relationships with other [*Enterococcus*](http://doi.org/10.1601/nm.5525) species and [*E. faecium*](http://doi.org/10.1601/nm.5535) strains, a phylogenetic tree was constructed using 16S rDNA sequences (Fig. [2](#Fig2){ref-type="fig"}). As expected, [*E. faecium*](http://doi.org/10.1601/nm.5535)[LMG 8148](http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DLMG+8148) forms a cluster with the other [*E. faecium*](http://doi.org/10.1601/nm.5535) strains.Table 1Classification and general features of *Enterococcus faecium* strain LMG 8148 according to the MIGS recommendations \[[@CR8]\]MIGS IDPropertyTermEvidence code^a^ClassificationDomain *Bacteria*TAS \[[@CR16]\]Phylum *Firmicutes*TAS \[[@CR17]\]Class *Bacilli*TAS \[[@CR18], [@CR19]\]Order *Lactobacillales*TAS \[[@CR19], [@CR20]\]Family *Enterococcaceae*TAS \[[@CR19], [@CR21]\]Genus *Enterococcus*TAS \[[@CR6]\]Species *Enterococcus faecium*TAS \[[@CR6]\]Strain LMG 8148NASGram stainPositiveTAS \[[@CR22]\]Cell shapeCoccusTAS \[[@CR22]\]MotilityNon-motileNASSporulationNon-sporulatingTAS \[[@CR7]\]Temperature range5-50 °CTAS \[[@CR7]\]Optimum temperature37 °CTAS \[[@CR23]\]pH range; Optimum4.6-9.9; 7.5TAS \[[@CR23]\]Carbon sourceGlucose, citrate, complex carbon sourcesTAS \[[@CR24], [@CR25]\]MIGS-6HabitatGastro-intestinal tracts of humans and other mammalsTAS \[[@CR5]\]MIGS-6.3Salinity0-6.5 %TAS \[[@CR7]\]MIGS-22Oxygen requirementFacultatively anaerobicTAS \[[@CR7]\]MIGS-15Biotic relationshipCommensalTAS \[[@CR5]\]MIGS-14PathogenicityPathogenicTAS \[[@CR5]\]MIGS-4Geographic locationSwedenNASMIGS-5Sample collection1961TAS \[[@CR4]\]MIGS-4.1LatitudeUnknownNASMIGS-4.2LongitudeUnknownNASMIGS-4.4AltitudeUnknownNAS^a^Evidence codes - *IDA* inferred from direct assay, *TAS* traceable author statement (i.e., a direct report exists in the literature); NAS: Non-traceable VAuthor Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project \[[@CR26]\]Fig. 1Phase-contrast micrograph of *E. faecium* LMG 8148Fig. 216S rRNA phylogenetic tree indicating the position of *E. faecium* LMG 8148 relative to other *E. faecium* strains and other enterococcal species (type strain = ^T^). *Lactobacillus plantarum* was included as an outgroup. Genbank accession numbers of the aligned sequences are indicated between brackets. 16S rDNA sequences were aligned using MUSCLE, and the phylogenetic tree was determined using the neighbour-joining algorithm with the Kimura 2-parameter distance model in MEGA (version 7) \[[@CR27]\]. A gamma distribution (shape parameter = 1) was used for rate variation among sites. The optimal tree with the sum of branch lengths = 0.1983 is shown, and nodes that appeared in more than 50 % of replicate trees in the bootstrap test (1000 replicates) are marked with their bootstrap support values

Genome sequencing information {#Sec4}
=============================

Genome project history {#Sec5}
----------------------

The strain [LMG 8148](http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DLMG+8148) was isolated from a human in Gothenburg ([Sweden](https://www.google.com/maps/place/Sweden)) in 1968 \[[@CR4]\]. The strain was obtained through the Belgian Coordinated Collection of Microorganisms. DNA samples were sequenced at the EMBL GeneCore facility ([Heidelberg, Germany](https://www.google.com/maps/place/Heidelberg,+Baden-Wurttemberg,+Germany)) and assembled using CLC Genomics Workbench (version 7.5.1). The draft genome was annotated using the NCBI Prokaryotic Genome Annotation Pipeline. This draft whole-genome sequence has been deposited at DDBJ/ENA/GenBank under the accession [LOHT00000000](https://www.ncbi.nlm.nih.gov/nuccore/LOHT00000000). The project information, and its association with MIGS version 2.0 \[[@CR8]\], is summarised in Table [2](#Tab2){ref-type="table"}.Table 2Project informationMIGS-IDPropertyTermMIGS-31Finishing qualityHigh-quality draftMIGS-28Libraries usedOne paired-end Illumina library (Nextera)MIGS-29Sequencing platformsIllumina HiSeq 2000MIGS-31.2Fold coverage317MIGS-30AssemblersCLC NGS Cell 7.5.1MIGS-32Gene calling methodGeneMarkS+Locus TagAUC59Genbank IDLOHT00000000GenBank Date of Release2016/02/26GOLD ID-BIOPROJECTPRJNA305395MIGS-13Source Material IdentifierLMG 8148Project relevanceEvolution

Growth conditions and genomic DNA preparation {#Sec6}
---------------------------------------------

Bacterial cultures were inoculated from single colonies on lysogeny broth agar in 5 ml of lysogeny broth and grown overnight at 37 °C, with 200 rpm orbital shaking. The DNeasy Blood&Tissue Kit (Qiagen) was used for DNA isolation, following the manufacturer's instructions and pre-treatment protocol for Gram-positive bacteria. Concentration and purity of isolated DNA was determined spectrophotometrically using the Nanodrop ND-1000 and fluorometrically using Qubit analysis (ThermoFisher Scientific).

Genome sequencing and assembly {#Sec7}
------------------------------

100 bp paired-end sequencing was performed on an Illumina HiSeq 2000 machine at the EMBL GeneCore facility in Heidelberg ([Germany](https://www.google.com/maps/place/Germany)). The total number of paired reads was 9,317,630. Sequencing data was analysed with the Qiagen CLC Genomics workbench version 7.5.1. After a trimming step for quality (score limit: 0.05) and ambiguous nucleotides (maximum 2 ambiguities), reads were assembled *de novo* using a mismatch cost of 2, a deletion cost of 3, an insertion cost of 3, length fraction 0.5, and similarity fraction 0.8. The assembly yielded 366 contigs (minimum length 200 bp) with an average coverage of 317× and an average contig length of 7,370 bp (N50 length of 41,184 bp). The total length of the draft genome is 2,697,490 bp with a GC-content of 38.3 %.

Genome annotation {#Sec8}
-----------------

All contigs were annotated using NCBI's Prokaryotic Genome Annotation Pipeline. Pfam domains \[[@CR9]\] in the predicted protein sequences were identified using the Batch Web CD-Search Tool from NCBI \[[@CR10]\]. Predicted proteins were classified into COG \[[@CR11]\] functional categories using the WebMGA web server for metagenomic analysis \[[@CR12]\]. For further characterization of the predicted genes, CRISPRFinder \[[@CR13]\], the SignalP 4.1 server \[[@CR14]\], and the TMHMM server \[[@CR15]\] were used to predict CRISPR repeats, signal peptides, and transmembrane domains, respectively. For the CRISPRFinder tool, only confirmed CRISPRs and not questionable CRISPRs were taken into account.

Genome properties {#Sec9}
=================

The properties of this draft genome are summarised in Table [3](#Tab3){ref-type="table"}. Assembly yielded 366 contigs containing 2,697,490 bp with a 38.3 % GC-content. The total number of 2,772 genes predicted by PGAP includes 2,402 protein coding genes (totalling 2,136,945 base pairs), 303 pseudo genes, and 67 RNA genes (56 tRNA and 11 rRNA genes). For 19.37 % of the protein-coding genes, no putative function was assigned, and these were annotated as hypothetical proteins. Further characteristics of the predicted genes are given in Table [3](#Tab3){ref-type="table"}, and classification into functional COG categories is shown in Table [4](#Tab4){ref-type="table"}.Table 3Genome statisticsAttributeValue% of TotalGenome size (bp)2,697,490100.00DNA coding (bp)2,136,94579.22DNA G + C (bp)1,034,25638.34DNA scaffolds366100.00Total genes2,772100.00Protein coding genes2,40286.65RNA genes672.42Pseudo genes30310.93Genes in internal clusters\--Genes with function prediction2,23580.63Genes assigned to COGs2,15377.67Genes with Pfam domains2,07874.96Genes with signal peptides1204.33Genes with transmembrane helices63122.76CRISPR repeats1-Table 4Number of genes associated with general COG functional categoriesCodeValue%ageDescriptionJ1506.24Translation, ribosomal structure and biogenesisA00.00RNA processing and modificationK1857.70TranscriptionL1486.16Replication, recombination and repairB00.00Chromatin structure and dynamicsD210.87Cell cycle control, cell division, chromosome partitioningV492.04Defense mechanismsT883.66Signal transduction mechanismsM1144.75Cell wall/membrane biogenesisN130.54Cell motilityU271.12Intracellular trafficking and secretionO582.41Posttranslational modification, protein turnover, chaperonesC743.08Energy production and conversionG25310.53Carbohydrate transport and metabolismE1446.00Amino acid transport and metabolismF783.25Nucleotide transport and metabolismH552.29Coenzyme transport and metabolismI572.37Lipid transport and metabolismP1094.54Inorganic ion transport and metabolismQ220.92Secondary metabolites biosynthesis, transport and catabolismR26310.95General function prediction onlyS24510.20Function unknown-24910.37Not in COGsThe total is based on the total number of protein coding genes in the genome

Conclusions {#Sec10}
===========

The presented genome sequence is from a strain isolated in 1968, and thus precedes the emergence of enterococci as important causative agents of hospital-acquired infections in the 1970s and 1980s \[[@CR2]\]. Consequently, this genome could be useful for comparative genomic studies looking to solve the remarkable recent emergence of [*E. faecium*](http://doi.org/10.1601/nm.5535) as a notorious nosocomial pathogen.

COG

:   Clusters of Orthologous Groups

PGAP

:   Prokaryotic genome annotation pipeline
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